CN114106850B - Positive liquid crystal composition and application thereof in liquid crystal display device - Google Patents

Positive liquid crystal composition and application thereof in liquid crystal display device Download PDF

Info

Publication number
CN114106850B
CN114106850B CN202111545219.6A CN202111545219A CN114106850B CN 114106850 B CN114106850 B CN 114106850B CN 202111545219 A CN202111545219 A CN 202111545219A CN 114106850 B CN114106850 B CN 114106850B
Authority
CN
China
Prior art keywords
liquid crystal
crystal composition
compound
formula
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111545219.6A
Other languages
Chinese (zh)
Other versions
CN114106850A (en
Inventor
史志兵
孙刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Hanlang Precision Technology Co ltd
Original Assignee
Chongqing Hanlang Precision Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Hanlang Precision Technology Co ltd filed Critical Chongqing Hanlang Precision Technology Co ltd
Priority to CN202111545219.6A priority Critical patent/CN114106850B/en
Publication of CN114106850A publication Critical patent/CN114106850A/en
Application granted granted Critical
Publication of CN114106850B publication Critical patent/CN114106850B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/44Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a positive liquid crystal composition and application thereof in a liquid crystal display device, wherein the liquid crystal composition comprises: the compound of the general formula I accounts for 0.01-60% of the total weight of the liquid crystal composition, the compound of the general formula II accounts for 1-60% of the total weight of the liquid crystal composition, the compound of the general formula III accounts for 1-60% of the total weight of the liquid crystal composition, and the compound of the general formula IV accounts for 0.1-40% of the total weight of the liquid crystal composition. The liquid crystal composition has the advantages of high bright point, low lower limit temperature of liquid crystal phase, low rotary viscosity, large elastic constant and the like, the anisotropy of the dielectric constant is positive, the refractive index anisotropy and the dielectric anisotropy value are moderate, and the response time of a liquid crystal display can be reduced, so that the problem of low response speed of the existing liquid crystal display device is solved, and the liquid crystal composition is suitable for TN-TFT, IPS, FFS and other types of liquid crystal display devices.

Description

Positive liquid crystal composition and application thereof in liquid crystal display device
Technical Field
The invention belongs to the field of liquid crystal display materials, and particularly relates to a positive liquid crystal composition and application thereof in a liquid crystal display device.
Background
The liquid crystal material is a mixture of organic rod-like small molecular compounds which have liquid fluidity and crystal anisotropy at a certain temperature, and is widely applied to liquid crystal display elements of devices such as automobile instruments, televisions, computers, word processors and the like due to the characteristics of optical anisotropy and dielectric anisotropy. Liquid crystal materials are generally used as a mixture of a plurality of components to exhibit characteristics that are difficult to exert by a single compound, and it is important that the liquid crystal compound as a component of the liquid crystal composition has good chemical and physical stability, a high clearing point, a low lower limit temperature of a liquid crystal phase, and appropriate dielectric anisotropy and refractive index anisotropy, and is well miscible with other liquid crystal compounds in the composition.
LCD displays, which are the most popular displays, have one of the most important properties of accurately reproducing moving images, and if the response speed of the liquid crystal composition used is too slow, the display may be left with afterimages, thereby affecting the appearance. The physical parameters that substantially determine the response time of the liquid crystal mixture are the rotational viscosity γ 1 and the elastic constant, which is also particularly important to ensure a good black state of the LCD, and generally the clearing point and the rotational viscosity of the liquid crystal composition increase with increasing elastic constant. Especially in LC displays for TV and video applications (e.g. LCD TV, monitor, PDA, notebook, game console), the demand for response time is higher. The response time can theoretically be accelerated by reducing the layer thickness d of the liquid-crystalline medium in the LC panel ("panel gap"), but to maintain a suitable optical retardation (d · Δ n), a liquid-crystalline composition with a higher birefringence Δ n is required, whereas highly birefringent liquid-crystalline materials known from the prior art usually also have a high rotational viscosity, which in turn affects the response time of the liquid-crystalline composition. Therefore, in the field of liquid crystal materials, there is a need for a novel liquid crystal composition with improved properties, which has both higher birefringence and low rotational viscosity, so as to improve the response rate of the liquid crystal display device.
Disclosure of Invention
The invention provides a positive liquid crystal composition with a substituted cyclohexenyl compound in order to overcome the defects and shortcomings of the prior art, and obtains the liquid crystal composition with stable physicochemical property, good low-temperature intersolubility, low rotary viscosity, large elastic constant and moderate refractive index anisotropy and dielectric anisotropy values by optimizing the components and the proportion in the liquid crystal composition.
In order to solve the technical problems, the invention provides the following technical scheme:
the first aspect of the present invention provides a positive liquid crystal composition comprising the following compounds:
(1) 0.01-60% of compound of general formula I in total weight of liquid crystal composition
Figure GDA0003790530090000021
(2) 1-60% of compound of general formula II based on total weight of liquid crystal composition
Figure GDA0003790530090000022
(3) 1-60% of compound of formula III based on total weight of liquid crystal composition
Figure GDA0003790530090000023
(4) 0.1-40% of compound of formula IV in total weight of liquid crystal composition
Figure GDA0003790530090000031
Wherein L is 1 represents-H, halogen substituted or unsubstituted C1-C12 alkyl, halogen substituted or unsubstituted C1-C12 alkoxy, or halogen substituted or unsubstituted C2-C12 alkenyl; or, L 1 Represents a halogen substituted or unsubstituted C1-C12 alkyl group, a halogen substituted or unsubstituted C1-C12 alkoxy group, or a halogen substituted or unsubstituted C2-C12 alkenyl group, one or more-CH groups among the alkyl, alkoxy or alkenyl groups 2 -each independently is substituted by-O-, -CH = CH-, -C ≡ C-, -CO-O-or-O-CO-in such a way that the oxygen atoms are not directly linked;
L 2 represents-H, halogen substituted or unsubstituted C1-C12 alkyl, or halogen substituted or unsubstituted C1-C12 alkoxy; or, L 2 Represents a halogen substituted or unsubstituted C1-C12 alkyl group, or a halogen substituted or unsubstituted C1-C12 alkoxy group, one or more-CH's in the alkyl or alkoxy group 2 -each independently is substituted by-O-, -CH = CH-, -C ≡ C-, -CO-O-or-O-CO-in such a way that the oxygen atoms are not directly linked;
L 3 represents-CF 3 Or, a fluorine substituted or unsubstituted alkoxy group having 1 to 5 carbon atoms;
rings A and B each independently represent
Figure GDA0003790530090000032
Figure GDA0003790530090000033
Z 1 、Z 2 Each independently of the other represents a single bond, -CH 2 O-、-CF 2 O-、-CH 2 CH 2 -、
Figure GDA0003790530090000034
Figure GDA0003790530090000035
X 1 、X 2 Each independently of the other represents hydrogen or fluorine;
m, n each independently of the other represent 0 or 1;
R A1 、R A2 each independently represents a C1-C12 alkyl group, a C1-C12 alkoxy group or a C2-C12 alkenyl group;
ring A 1 、A 2 Each independently of the other
Figure GDA0003790530090000041
Z A represents-CH 2 CH 2 -、-CH=CH-、-CF 2 O-、-OCF 2 -、-CH 2 O-、-OCH 2 -、-CO-O-、-CH 2 CH 2 -, -CF = CF-or a single bond;
R B1 represents a C1-C12 alkyl group, a C1-C12 alkoxy group or a C2-C12 alkenyl group;
R B2 represents C1-C12 alkyl, C1-C12 alkoxy, C2-C12 alkenyl, -F, -Cl, -OCF 3 or-CF 3
Ring B 1 、B 2 Each independently of the other
Figure GDA0003790530090000042
Figure GDA0003790530090000043
L B1 、L B2 Each independently of the other represents-H, -F, -Cl, -OCF 3 or-CF 3
Z B1 、Z B2 Each independently of the other represents-CH 2 CH 2 -、-CH=CH-、-CF 2 O-、-OCF 2 -、-CH 2 O-、-OCH 2 -、-CO-O-、-CF 2 CF 2 -, -CF = CF-or a single bond;
R 41 、R 42 each independently of the other represents C1-C12 alkyl, C1-C12 alkoxy, -F, -Cl, -OCF 3 or-CF 3
Ring C 1 、C 2 、C 3 、C 4 Each independently of the other
Figure GDA0003790530090000044
Figure GDA0003790530090000045
Z 41 、Z 42 、Z 43 Each independently of the other represents-CH 2 CH 2 -、-CH=CH-、-CF 2 O-、-OCF 2 -、-CH 2 O-、-OCH 2 -、-CO-O-、-CF 2 CF 2 -, -CF = CF-, or a single bond.
Further, the compound of the general formula I accounts for 0.01-50% of the total weight of the liquid crystal composition; the compound of the general formula II accounts for 5-50% of the total weight of the liquid crystal composition; the compound of the general formula III accounts for 5-50% of the total weight of the liquid crystal composition; the compound of the general formula IV accounts for 0.5-40% of the total weight of the liquid crystal composition.
Further, the compound of the general formula I accounts for 0.01-40% of the total weight of the liquid crystal composition.
Further, the compound of the general formula I is selected from one or more compounds in the following general formulas I-A-I-P:
Figure GDA0003790530090000051
Figure GDA0003790530090000061
wherein R is 1 represents-H, a halogen substituted or unsubstituted C1-C5 alkyl group, or a halogen substituted or unsubstituted C1-C5 alkoxy group; or, R 1 Represents a halogen substituted or unsubstituted C1-C5 alkyl group, or a halogen substituted or unsubstituted C1-C5 alkoxy group, one or more-CH's in the alkyl or alkoxy group 2 -each independently is substituted by-O-, -CH = CH-, -C ≡ C-, -CO-O-or-O-CO-in such a way that the oxygen atoms are not directly linked;
R 2 represents-H, halogen substituted or unsubstituted C1-C5 alkyl, or halogen substituted or unsubstituted C1-C5 alkoxy; or, R 2 Represents a halogen substituted or unsubstituted C1-C5 alkyl group, or a halogen substituted or unsubstituted C1-C5 alkoxy group, one or more-CH's in the alkyl or alkoxy group 2 -each independently is substituted by-O-, -CH = CH-, -C ≡ C-, -CO-O-or-O-CO-in such a way that the oxygen atoms are not directly linked;
X 1 、X 2 each independently of the other represents hydrogen or fluorine.
Further, the compound of the general formula I is selected from one or more of the following compounds:
Figure GDA0003790530090000071
Figure GDA0003790530090000081
Figure GDA0003790530090000091
Figure GDA0003790530090000101
further, the compound of formula II is selected from one or more of the following compounds:
Figure GDA0003790530090000102
Figure GDA0003790530090000111
Figure GDA0003790530090000121
further, the compound of formula III is selected from one or more of the following compounds:
Figure GDA0003790530090000122
Figure GDA0003790530090000131
Figure GDA0003790530090000141
Figure GDA0003790530090000151
Figure GDA0003790530090000161
Figure GDA0003790530090000171
further, the compound of formula IV is selected from one or more of the following compounds:
Figure GDA0003790530090000172
Figure GDA0003790530090000181
Figure GDA0003790530090000191
Figure GDA0003790530090000201
further, the compound of formula I in the liquid crystal composition is preferably one or more of the compounds shown in the formulas I-23, I-30, I-40, I-41, I-43, I-44, I-48, I-50 and I-68.
Further, the compound of formula II in the liquid crystal composition is preferably one or more of the compounds shown in the formulas II-12, II-14, II-15 and II-33.
Further, the compound of formula III in the liquid crystal composition is preferably one or more of the compounds represented by the above formulae III-15, III-16, III-18, III-23, III-89, III-93, III-98, III-104, III-105, III-109, and III-112 to III-117.
Further, the compound of formula IV in the liquid crystal composition is preferably one or more of the compounds represented by the above formulae IV-53, IV-54, IV-57, IV-58, IV-61 to IV-64, IV-69, IV-74 and IV-75.
The second aspect of the present invention provides a liquid crystal composition according to the first aspect for use in a liquid crystal display device.
Further, the liquid crystal display device comprises VA, MVA, PVA, PSVA, TN-TFT, IPS and FFS mode liquid crystal display devices.
Further, the liquid crystal display device is preferably an IPS or FFS mode liquid crystal display device.
Further, the liquid crystal display device includes an upper substrate and a lower substrate, wherein at least one of the substrates has one or two electrodes thereon, and at least one of the substrates is relatively light-transparent.
Compared with the prior art, the invention has the beneficial effects that:
1. the positive liquid crystal composition provided by the invention comprises one or more compounds containing trifluoromethyl substituted cyclohexenyl in the formula I, and the compounds have larger elastic constants and good low-temperature intersolubility with compounds in the formulae II, III, IV and the like in the composition.
2. The positive liquid crystal composition composed of the compounds of the formulas I, II, III and IV has the advantages of stable physical and chemical properties, good low-temperature intersolubility, low rotational viscosity, large elastic constant, low lower limit temperature of a liquid crystal phase and the like, and the dielectric anisotropy and the refractive index anisotropy are moderate, so that the low-temperature working effect of a liquid crystal display device can be improved, the low-temperature working range is enlarged, and the contrast and the response speed of the liquid crystal display are improved.
Detailed Description
The present invention is further described below with reference to specific examples so that those skilled in the art can better understand the present invention and can practice the present invention, but the examples are not intended to limit the present invention.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
The experimental methods used in the following examples are conventional methods unless otherwise specified, and materials, reagents and the like used therein are commercially available without otherwise specified.
The liquid crystal displays used in the following examples and comparative examples, each of which is an IPS liquid crystal display device, were subjected to a performance test by filling a liquid crystal composition between two substrates of a liquid crystal device, wherein the abbreviated symbols of the test items are as follows:
cp: clearing point (nematic-isotropic phase transition temperature);
Δ n: refractive index anisotropy (589nm, 25 ℃);
Δ ε: dielectric anisotropy (test condition: 1K Hz,25 ℃);
γ 1 : represents the rotational viscosity [ mPas ] measured at 25 DEG C];
K11: splay elastic constant (pN, 25 ℃ C.)
K33: flexural modulus of elasticity constant (pN, 25 ℃ C.)
Wherein Δ ε = ε || Wherein epsilon || Is the dielectric constant, ε, parallel to the molecular axis Is the dielectric constant perpendicular to the molecular axis.
The compounds of formula I used in the following examples were prepared by the following preparation methods:
synthesis of Compounds of formula I-40:
Figure GDA0003790530090000221
36.6g 100mmol of 4 '-propyl-4- (4- (trifluoromethyl) phenyl) - [1,1' -bis (cyclohexane) ] -3-one, 110mmol of trimethyl (trifluoromethyl) silane and 100mmol of tetrabutylammonium fluoride are added to 500mL of THF, the reaction is stirred for 2 hours while cooling to 0 ℃ and the crude product is isolated. The crude product was dissolved in 200mL of THF, 18g of diethylaminosulfur trifluoride was added, the mixture was refluxed for 3 hours, and the separated solid was recrystallized and subjected to column chromatography to obtain 29.2g of a compound of the formula I-40, GC 99.9%, GC-MS: E/Z =418.2.
1 H NMR(500MHz,CDCl 3 )δ7.73-7.67(m,2H),7.47-7.41(m,2H),2.85-2.68(m,2H),2.46-2.35(m,2H),1.99(tdt,J=8.8,7.3,5.9Hz,1H),1.89-1.13(m,19H),0.90(t,J=7.5Hz,3H)。
Synthesis of Compounds of formula I-48:
Figure GDA0003790530090000222
36.6g 100mmol of 4 '-propyl-4- (4- (trifluoromethoxy) phenyl) - [1,1' -bis (cyclohexane) ] -3-one, 110mmol of trimethyl (trifluoromethyl) silane and 100mmol of tetrabutylammonium fluoride were added to 500mL of THF, the reaction was stirred for 2 hours while cooling to 0 ℃ and the crude product was isolated. The crude product was dissolved in 200mL of THF, 18g of diethylaminosulfur trifluoride was added, the mixture was refluxed for 3 hours, and the isolated solid was recrystallized and subjected to column chromatography to obtain 30.1g of a compound of formula I-48, GC 99.9%, GC-MS: E/Z =434.2.
1 H NMR(500MHz,CDCl 3 )δ7.56-7.39(m,1H),7.28-7.02(m,1H),2.93-2.59(m,1H),2.56-2.23(m,1H),2.12-1.08(m,10H),0.90(t,J=7.5Hz,1H)。
Other compounds of formula I can be synthesized in a similar manner by substituting the starting materials and the corresponding trimethylsilane.
Example 1
The liquid crystal composition provided by the embodiment comprises the following components:
(1) 4.5 percent of compound of formula I-40 based on the total weight of the liquid crystal composition;
(2) 59.5% by weight of the total liquid crystal composition of a compound of formula II: 48.5% of formula II-12, 5% of formula II-15 and 6% of formula II-33, respectively;
(3) 29% by weight of the total liquid crystal composition of a compound of formula III: 5% of formula III-16, 3% of formula III-115, 15% of formula III-116, 2% of formula III-117 and 4% of formula III-93, respectively;
(4) 7% by weight of the total liquid crystal composition of a compound of formula IV: 1% of IV-53 and 6% of IV-63 compounds, respectively.
Example 2
The present embodiment provides a liquid crystal composition comprising the following components:
(1) 18.5% by weight of the total liquid crystal composition of a compound of formula I: comprising formula 7.5% of I-48 and 11% of a compound of formula I-40;
(2) 49.5% by weight of the total liquid crystal composition of a compound of formula II: 40% of formula II-12, 2% of formula II-15 and 7.5% of formula II-33, respectively;
(3) 31.5% by weight of the total liquid crystal composition of a compound of formula III: 3% of formula III-93, 10% of formula III-112, 10.5% of formula III-113 and 8% of formula III-114, respectively;
(4) 0.5% by weight of the total liquid crystal composition of a compound of formula IV-54.
Example 3
The present embodiment provides a liquid crystal composition comprising the following components:
(1) 6% by weight of the total liquid crystal composition of a compound of formula I-68;
(2) 50% by weight of the total liquid crystal composition of a compound of formula II: 34% of formula II-12, 6% of formula II-15 and 10% of formula II-33, respectively;
(3) 40.5% by weight of the total liquid crystal composition of a compound of formula III: 2% of formula III-16, 4% of formula III-18, 6.5% of formula III-98, 10% of formula III-105, 7% of formula III-112 and 11% of formula III-113, respectively;
(4) 3.5% by weight of the total liquid crystal composition of a compound of formula IV: 3% of IV-64 and 0.5% of IV-53 respectively.
Example 4
The present embodiment provides a liquid crystal composition comprising the following components:
(1) 7% by weight of the total liquid crystal composition of a compound of formula I-50;
(2) 50% by weight of the total liquid crystal composition of a compound of formula II: 44% of formula II-12 and 6% of formula II-15, respectively;
(3) 15% by weight of the total liquid crystal composition of a compound of formula III: 7% of formula III-16, 5% of formula III-109, 3% of formula III-105, respectively;
(4) 28% by weight of the total liquid crystal composition of a compound of formula IV: respectively 6% IV-58, 4% IV-64, 6% IV-63, 6% IV-69 and 6% IV-75.
Example 5
The present embodiment provides a liquid crystal composition comprising the following components:
(1) 6% by weight of the total liquid crystal composition of a compound of formula I-44;
(2) 45% by weight of the total liquid crystal composition of a compound of formula II: 26% of formula II-12, 9% of formula II-14 and 10% of formula II-15, respectively;
(3) 34% by weight of the total liquid crystal composition of a compound of formula III: 11% of formula III-16, 8% of formula III-23, 2% of formula III-89, 3% of formula III-98 and 10% of formula III-116, respectively;
(4) 15% by weight of the total liquid crystal composition of a compound of formula IV: respectively 7% IV-62, 2% IV-63 and 6% IV-69.
Example 6
The present embodiment provides a liquid crystal composition comprising the following components:
(1) 13.5% by weight of the total liquid crystal composition of a compound of formula I: comprising formula 5% of I-23, formula 3.5% of I-30, and formula 5% of a compound of formula I-41;
(2) 59.5% by weight of the total liquid crystal composition of a compound of formula II: 44% of formula II-12, 10% of formula II-15 and 5.5% of formula II-33, respectively;
(3) 16% by weight of the total liquid crystal composition of a compound of formula III: 10% of formula III-15 and 6% of formula III-116, respectively;
(4) 11% by weight of the total liquid crystal composition of a compound of formula IV: respectively 0.5% of IV-54, 4.5% of IV-57 and 6% of IV-61.
Example 7
The liquid crystal composition provided by the embodiment comprises the following components:
(1) I-43 accounting for 6 percent of the total weight of the liquid crystal composition;
(2) 59.5% by weight of the total liquid crystal composition of a compound of formula II: 47% of formula II-44, 10.5% of formula II-15 and 2% of formula II-33, respectively;
(3) 24% by weight of the total liquid crystal composition of a compound of formula III: 6% of formula III-15, 7% of formula III-18 and 11% of formula III-115, respectively;
(4) 10.5% by weight of the total liquid crystal composition of a compound of formula IV: respectively 0.5% IV-54, 5% IV-57 and 5% IV-61.
Example 8
The present embodiment provides a liquid crystal composition comprising the following components:
(1) I-41 accounting for 4 percent of the total weight of the liquid crystal composition;
(2) 49% by weight of the total liquid crystal composition of a compound of formula II: 35% of formula II-12, 5% of formula II-15 and 9% of formula II-33, respectively;
(3) 36% by weight of the total liquid crystal composition of a compound of formula III: 3% of formula III-15, 4% of formula III-104, 10% of formula III-112, 7% of formula III-113 and 12% of formula III-114, respectively;
(4) 11% by weight of the total liquid crystal composition of a compound of formula IV: respectively 0.5% IV-54, 3% IV-61, 4% IV-69 and 3.5% IV-74.
Comparative example 1
This comparative example uses compounds of formulas III-109 in place of the compounds of formulas I-40 of example 1, with the remaining components and proportions unchanged.
Comparative example 2
This comparative example replaces 40% of the formula II-12, 2% of the formula II-15 and 7.5% of the formula II-33 of example 2 with 40% of the formula III-1, 2% of the formula III-15 and 7.5% of the formula III-18, the other components and proportions being unchanged.
Comparative example 3
This comparative example replaces 7% of the formula III-16, 5% of the formula III-109 and 3% of the formula III-105 of example 4 with 7% of the formula II-17, 5% of the formula II-29 and 3% of the formula II-33, the remaining components and proportions being unchanged.
Comparative example 4
This comparative example replaces 7% IV-62, 2% IV-63 and 6% IV-69 of example 5 with 7% III-89, 2% III-93 and 6% III-99, the remaining components and proportions being unchanged.
Performance testing and comparison
The liquid crystal compositions prepared in examples 1 to 8 and comparative examples 1 to 4 were filled between two substrates of a display, respectively, and Cp, Δ n, Δ ε, and γ for the constructed liquid crystal display 1 K11, K33 and low temperature storage crystallization properties were tested and studied.
(1) Effect of compounds of formula I on liquid crystal composition properties: the test data of the liquid crystal display of the liquid crystal composition described in example 1 and comparative example 1 are shown in the following table 1:
TABLE 1 Performance test parameters of liquid Crystal display comprising the liquid Crystal composition of example 1 or comparative example 1
Test item Example 1 Comparative example 1
Cp(℃) 75 75
Δn 0.118 0.120
Δε 2.2 2.4
γ 1 44 52
Storage at-30 deg.C Does not crystallize in 10 days Crystallization for 7 days
K11 14.3 13.9
K33 14.8 13.8
As can be seen from the performance test data in Table 1, the liquid crystal composition added with the compound I-40 has a significantly reduced rotational viscosity, while the refractive index anisotropy and the dielectric anisotropy are only slightly reduced, and furthermore, the elastic constant (K33/K11) of the liquid crystal composition of example 1 is increased compared with that of comparative example 1, and the liquid crystal composition does not crystallize after being stored at-30 ℃ for 10 days, which is beneficial to improving the low temperature operation effect of the liquid crystal display device and increasing the low temperature operation range.
(2) Effect of compounds of formula II on the properties of liquid crystal compositions: the test data of the liquid crystal display of the liquid crystal composition described in example 2 and comparative example 2 are shown in the following table 2:
table 2 parameters for the Performance test of a liquid Crystal display comprising the liquid Crystal composition of example 2 or comparative example 2
Test items Example 2 Comparative example 2
Cp(℃) 78.5 88
Δn 0.117 0.135
Δε 2.3 2.5
γ 1 49 78
Storage at-30 deg.C Does not crystallize in 10 days 1 day crystallization
K11 14.9 12.4
K33 15.1 12.9
As can be seen from the performance test data in Table 2 above, the liquid crystal composition of comparative example 2, which does not contain the compound of formula II, has a significant increase in rotational viscosity, and is crystallized upon standing at-30 ℃ for 1 day, indicating that the presence of the compound of formula II reduces the viscosity while increasing the crystallization temperature of the liquid crystal composition.
(3) Effect of the compound of formula III on the properties of liquid crystal compositions: the test data of the liquid crystal displays of the liquid crystal compositions described in example 4 and comparative example 3 are shown in table 3 below:
table 3 parameters for Performance test of liquid Crystal display comprising liquid Crystal composition of example 4 or comparative example 3
Test items Example 4 Comparative example 3
Cp(℃) 78.5 68.5
Δn 0.100 0.085
Δε 9.4 6.3
γ 1 62 56
Storage at-30 deg.C Does not crystallize in 10 days 5 days devitrification
K11 13.3 12.5
K33 15.4 13.8
As can be seen from the performance test data in Table 3 above, the liquid crystal composition of comparative example 3, which does not contain the compound of formula III, has a lower dielectric anisotropy value and clearing point, and is easily crystallized at low temperature, although the rotational viscosity is slightly lower than that of example 4.
(4) Effect of compounds of formula IV on liquid crystal composition properties: the test data of the liquid crystal displays of the liquid crystal compositions described in example 5 and comparative example 4 are shown in table 4 below:
table 4 Performance test parameters of liquid Crystal display comprising liquid Crystal composition of example 5 or comparative example 4
Test items Example 5 Comparative example 4
Cp(℃) 105 99
Δn 0.119 0.123
Δε 5.2 3.8
γ 1 85 89
Storage at-30 deg.C Does not crystallize in 10 days 3 days crystallization
K11 19.7 14.3
K33 19.4 16.2
As can be seen from the performance test data in Table 4 above, the liquid crystal composition of comparative example 4, which does not contain the compound of formula IV, has an adverse effect on the rotational viscosity, dielectric anisotropy, clearing point, and crystallization properties.
The test data for the liquid crystal displays constructed from the different liquid crystal compositions of example 3 and examples 6-8 are shown in table 5 below:
TABLE 5 Performance test parameters for liquid Crystal displays comprising different liquid Crystal compositions
Test items Example 3 Example 6 Example 7 Example 8
Cp(℃) 74.5 81 75.4 78.4
Δn 0.131 0.125 0.094 0.149
Δε 5.3 2.9 2.7 3.8
γ 1 54 49 48 52
Storage at-30 deg.C Does not crystallize in 10 days Does not crystallize in 10 days Does not crystallize in 10 days Does not crystallize in 10 days
K11 15.8 15.5 14.7 13.4
K33 15.2 17.2 16.3 14.2
The above-mentioned embodiments are merely preferred embodiments for fully illustrating the present invention, and the scope of the present invention is not limited thereto. The equivalent substitution or change made by the technical personnel in the technical field on the basis of the invention is all within the protection scope of the invention. The protection scope of the invention is subject to the claims.

Claims (8)

1. A positive liquid crystal composition, characterized in that it comprises the following compounds:
(1) The compound of the general formula I accounts for 4-40% of the total weight of the liquid crystal composition
Figure FDA0003804199770000011
(2) 45-60% of compound of general formula II based on total weight of liquid crystal composition
Figure FDA0003804199770000012
(3) 15-50% of compound of general formula III based on total weight of liquid crystal composition
Figure FDA0003804199770000013
(4) 0.5-40% of compound of general formula IV in total weight of liquid crystal composition
Figure FDA0003804199770000014
Wherein the sum of all liquid crystal components in the liquid crystal composition is 100 percent;
L 1 represents-H, a halogen substituted or unsubstituted C1-C12 alkyl group;
L 2 represents-H, halogen substituted or unsubstituted C1-C12 alkyl, or halogen substituted or unsubstituted C1-C12 alkoxy;
L 3 denotes-CF 3
Rings A and B each independently represent
Figure FDA0003804199770000021
Z 1 、Z 2 Each independently represents a single bond, -CF 2 O-、
Figure FDA0003804199770000022
X 1 、X 2 Each independently represents hydrogen or fluorine;
m and n each independently represent 0 or 1;
R A1 、R A2 each independently represents a C1-C12 alkyl group or a C2-C12 alkenyl group;
ring A 1 、A 2 Each independently represent
Figure FDA0003804199770000023
Z A Represents a single bond;
R B1 represents a C1-C12 alkyl group or a C2-C12 alkenyl group;
R B2 represents C1-C12 alkyl, C1-C12 alkoxy, -F or-OCF 3
Ring B 1 、B 2 Each independently represent
Figure FDA0003804199770000024
L B1 、L B2 Each independently represents-H or-F;
Z B1 、Z B2 each independently represents-CF 2 O-、-OCF 2 -or a single bond;
and when R is B1 Is butenyl, R B2 Is methyl, ethyl or propyl, ring B 1 Is composed of
Figure FDA0003804199770000025
L B1 、L B2 Are all-H, Z B1 、Z B2 When all are single bonds, ring B 2 Is composed of
Figure FDA0003804199770000026
R 41 、R 42 Each independently represents a C1-C12 alkyl group or-F;
ring C 1 、C 2 、C 3 、C 4 Each independently represent
Figure FDA0003804199770000027
Figure FDA0003804199770000031
Z 41 、Z 42 、Z 43 Each independently represents-CF 2 O-、-OCF 2 -or a single bond.
2. A positive-working liquid crystal composition according to claim 1, wherein the compound of formula I is selected from one or more compounds of the following formulae:
Figure FDA0003804199770000032
wherein R is 1 represents-H, a halogen substituted or unsubstituted C1-C5 alkyl group;
R 2 represents-H, halogen substituted or unsubstituted C1-C5 alkyl, or halogen substituted or unsubstituted C1-C5 alkoxy;
X 1 、X 2 each independently of the other represents hydrogen or fluorine.
3. A positive working liquid crystal composition according to claim 1, wherein the compound of formula I is selected from one or more of the following compounds;
Figure FDA0003804199770000041
Figure FDA0003804199770000051
Figure FDA0003804199770000061
Figure FDA0003804199770000071
4. a positive working liquid crystal composition according to claim 3, wherein the compound of formula I is selected from one or more compounds of formulae I-23, I-30, I-40, I-41, I-43, I-44, I-48, I-50 and I-68.
5. A positive-working liquid crystal composition according to claim 1, wherein the compound of formula II is selected from one or more of the following compounds:
Figure FDA0003804199770000072
Figure FDA0003804199770000081
6. a positive-working liquid crystal composition according to claim 1, wherein the compound of formula III is selected from one or more of the following compounds:
Figure FDA0003804199770000091
Figure FDA0003804199770000101
Figure FDA0003804199770000111
Figure FDA0003804199770000121
Figure FDA0003804199770000131
7. a positive-working liquid crystal composition according to claim 1, wherein the compound of formula IV is selected from one or more of the following compounds:
Figure FDA0003804199770000141
Figure FDA0003804199770000151
Figure FDA0003804199770000161
Figure FDA0003804199770000171
8. use of the positive liquid crystal composition according to any one of claims 1 to 7 in a liquid crystal display device comprising a VA, MVA, PVA, PSVA, TN-TFT, IPS, FFS type liquid crystal display device.
CN202111545219.6A 2021-12-17 2021-12-17 Positive liquid crystal composition and application thereof in liquid crystal display device Active CN114106850B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111545219.6A CN114106850B (en) 2021-12-17 2021-12-17 Positive liquid crystal composition and application thereof in liquid crystal display device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111545219.6A CN114106850B (en) 2021-12-17 2021-12-17 Positive liquid crystal composition and application thereof in liquid crystal display device

Publications (2)

Publication Number Publication Date
CN114106850A CN114106850A (en) 2022-03-01
CN114106850B true CN114106850B (en) 2022-11-18

Family

ID=80365224

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111545219.6A Active CN114106850B (en) 2021-12-17 2021-12-17 Positive liquid crystal composition and application thereof in liquid crystal display device

Country Status (1)

Country Link
CN (1) CN114106850B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006073A1 (en) * 1994-08-18 1996-02-29 Wojskowa Akademia Techniczna Liquid crystal materials
WO1998011173A1 (en) * 1996-09-12 1998-03-19 Samsung Display Devices Co., Ltd. Liquid crystal materials
JPH10236989A (en) * 1997-02-27 1998-09-08 Chisso Corp Liquid crystal compound having negative anisotropic value of dielectric constant, liquid crystal composition containing the same and liquid crystal display element using the composition
CN101506330A (en) * 2006-08-16 2009-08-12 默克专利股份有限公司 New cyclohexene-compounds useful as a component in a liquid crystal medium
CN102186945A (en) * 2008-09-17 2011-09-14 特拉根Lc化学股份公司 Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions
CN103897708A (en) * 2014-03-13 2014-07-02 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropy liquid crystal composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10124481A1 (en) * 2000-06-28 2002-01-10 Merck Patent Gmbh New trans-2-substituted-1,4-cyclohexylene compounds are used as chiral dopant and in liquid crystal medium for use in liquid crystal display or as dielectric in electrooptical display
KR100821844B1 (en) * 2005-01-13 2008-04-11 주식회사 엘지화학 Liquid crystal composition comprising novel silicon containing compounds and liquid crystal display device using the same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006073A1 (en) * 1994-08-18 1996-02-29 Wojskowa Akademia Techniczna Liquid crystal materials
WO1998011173A1 (en) * 1996-09-12 1998-03-19 Samsung Display Devices Co., Ltd. Liquid crystal materials
JPH10236989A (en) * 1997-02-27 1998-09-08 Chisso Corp Liquid crystal compound having negative anisotropic value of dielectric constant, liquid crystal composition containing the same and liquid crystal display element using the composition
CN101506330A (en) * 2006-08-16 2009-08-12 默克专利股份有限公司 New cyclohexene-compounds useful as a component in a liquid crystal medium
CN102186945A (en) * 2008-09-17 2011-09-14 特拉根Lc化学股份公司 Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions
CN103897708A (en) * 2014-03-13 2014-07-02 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropy liquid crystal composition

Also Published As

Publication number Publication date
CN114106850A (en) 2022-03-01

Similar Documents

Publication Publication Date Title
KR102080953B1 (en) Liquid Crystal Compound And Liquid Crystal Mixture Containing Cyclopropyl
CN108865175B (en) Liquid crystal composition containing dibenzofuran and application thereof
CN108728117B (en) Liquid crystal composition and display device thereof
JP6315156B2 (en) Liquid crystal composition and liquid crystal display device using the same
CN104428396A (en) Nematic liquid crystal composition and liquid crystal display device using same
JP4639621B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
TW201341511A (en) Liquid crystal composition and its display device
KR101982119B1 (en) Positive dielectric liquid crystal composition
JP3904094B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
JP4655479B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
CN109880635B (en) Liquid crystal compound containing dibenzofuran-oxygen-containing heterocyclic ring, composition and application
US20040119051A1 (en) Liquid crystal composition having high-speed response property and liquid crystal display using the same
CN113667493A (en) Liquid crystal composition and liquid crystal display device
CN114106850B (en) Positive liquid crystal composition and application thereof in liquid crystal display device
CN113773854B (en) Liquid crystal composition with positive dielectric constant and application thereof
CN109575944B (en) Liquid crystal composition and liquid crystal display device thereof
JPH09157654A (en) Nematic liquid crystal composition and liquid crystal display device using the same
JPH09151376A (en) Nematic liquid crystal composition and liquid crystal display using the same
TWI802817B (en) A liquid crystal composition and an optoelectronic display device
CN114196423A (en) Liquid crystal composition containing positive and negative liquid crystal compounds and application thereof
CN109825308B (en) Negative liquid crystal compound, negative liquid crystal composition and application
CN109575945B (en) Liquid crystal composition and liquid crystal display device thereof
JP2001019965A (en) Liquid crystal composition and liquid crystal display element
CN112048314B (en) Liquid crystal composition and display device thereof
CN112048320B (en) Liquid crystal composition and display device thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220921

Address after: 1-1, 1-2, 2-1, 2-2, Building 3, No. 16, Shigui Avenue, Jieshi Town, Banan District, Chongqing 401320,

Applicant after: Chongqing hanlang Precision Technology Co.,Ltd.

Address before: 215123 room 808, floor 8, building 1, Zone C, Sangtian Island Science and Innovation Park, Huayun Road, Suzhou Industrial Park, Jiangsu Province

Applicant before: HALATION PHOTONICS Corp.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant